Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Caulophyllogenin
Cat. No.:
OB0425LY-325
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Caulophyllogenin is a triterpene saponin extracted from M. polimorpha. Moreover, it is a partial PPARγ agonist.
Synonyms:
52936-64-8; (4aR,5R,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-5,10-Dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
CAS No.:
52936-64-8
Compound CID:
104361
Formula:
C30H48O5
Formula Weight:
488.7
Specification
Source:
M. polimorpha
Target:
PPAR
Pathway:
Cell cycle/DNA damage
Storage:
Storage at -20°C.
Applications:
Caulophyllogenin can be used in type-2 diabetes, obesity, metabolic syndrome and inflammation studies.
